Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences

Advancement In Latest Therapeutic and Revolutionary Immunization with Vaccines
- Euro Vaccines 2018



Euro Vaccines 2018

The International Conference on Vaccines and Immunology was organized on June 28-29, 2018 at the Hyatt Place Amsterdam Airport, Amsterdam, Netherlands. The conference was marked with the attendance of Editorial Board Members of supported Allied Academies Journals, Scientists, young and brilliant researchers and talented student communities representing more than 10 countries, who made this conference fruitful and productive.

This conference was based on the Theme - "Advancement In Latest Therapeutic and Revolutionary Immunization with Vaccines” which included the following scientific tracks:

  • Vaccine & Immunization
  • Latest developed vaccine
  • Vaccines & Immunotherapy
  • Immunological Clinical Practices &Trials
  • Immunological Disorders
  • Production and effectiveness of vaccines
  • Veterinary vaccines
  • Cancer vaccines & Immunotherapy
  • Pediatric vaccines
  • Types of vaccines
  • Immunology Of Infectious Diseases
  • Human Vaccines-infectious & non- infectious
  • Vaccine adjuvants & delivery technologies
  • Vaccines for unconventional diseases
  • Plant –based vaccines
  • Vaccines safety and efficiency
  • Current research and future challenges in vaccines
  • Society and cultural aspects of vaccines
  • Immunoresearch & Immunotechnology

Euro Vaccines 2018 was moderated by Rashmi Dixit (Australasian College of Travel and Tropical Medicine, Australia) on the First and Second day of the Conference.

We are grateful to our Organizing Committee Members for their generous support and suggestions for the conference.

  • Pierre A Morgon – MRGN Advisors, Switzerland
  • Zelalem Bitsue – United States of African Health Organization (US-AHO), Ethiopia

The conference proceeded through various Scientific Sessions and plenary lectures, of which the topics were highlighted as Keynote Presentations and Special Sessions.

Scientific sessions were chaired by: Pierre A Morgon, MRGN Advisors, Switzerland

Allied Academies has taken the grand privilege of felicitating Euro Vaccines 2018 Organizing Committee, Editorial Board Members and Keynote Speakers who supported for the success of this event.

The esteemed guests, Keynote speakers, well-known researchers and delegates shared their innovative research and vast experience through their presentations at the podium of Euro Vaccines 2018. We are glad to inform that all accepted abstracts for the conference have been published in the Asian Journal of Biomedical and Pharmaceutical Sciences as a special issue.

We are also obliged to various delegate experts, company representatives and other eminent personalities who supported the conference by facilitating active discussion forums. We sincerely thank the Organizing Committee Members for their gracious presence, support, and assistance. With the unique and positive feedback from the conference, Allied Academies would like to announce the commencement of the "4th International Conference on Vaccines and Immunology" which is being organized during April 17-18, 2019 at Rome, Italy.  


About Conference

ALLIED ACADEMIES every year hosts interdisciplinary international conferences worldwide on cutting-edge basic and applied research in life sciences, Pharma, medicine, healthcare and nursing delivered by the best talents in industry and academia. Our conferences are oriented to drive the scientific community at large, facilitating access to the newest technical and scientific achievements and to shape future research directions through the publication of applied and theoretical research findings of the highest quality.


Allied Academies  invites all the participants from all across the globe to attend "International Conference on Vaccines and Immunology”, on June 28-29, 2018 in Amsterdam, Netherlands, which includes prompt keynote presentations, poster presentations, oral talks, and exhibitions.

Euro Vaccines 2018  means to unite the Professors, researchers, business mammoths, and technocrats to give a global gathering to the spread of unique research comes about, new thoughts and viable improvement and find progresses in the field of Vaccine, Immunization and Vaccination, administration and instruction in connection to Vaccine, Immunization and Vaccination and additionally an expansiveness of different subjects.

This meeting makes a stage for Policy-creators, Scientists, agents and leaders in Vaccine, Immunization and Vaccination to display their most recent research and find out about all the imperative advancements in Vaccine, Immunization and Vaccination. Real subjects talked about are Latest developed vaccines, Production and effectiveness of vaccines, Types of vaccines, Veterinary vaccines, Pediatric vaccines, Vaccines against drugs, Vaccines and autism, Vaccines for unconventional diseases, Animal and plant derived vaccines, Vaccines safety and efficiency, Current research and future challenges in vaccines, Society and cultural aspects of vaccines.


Euro Vaccines 2018  is a platform to achieve the prevailing gaps in the transformation of this multidisciplinary science of hope, to serve promptly with solutions to all in the need. Euro Vaccines 2018 will have an anticipated participation of 120+ delegates across the world to discuss the purpose of the conference.

Euro Vaccines 2018  unites people who have an enthusiasm for various fields of Vaccine, Immunization and Vaccination. Target Audience will be work force from both mechanical and scholastic fields which incorporate; Professors, researchers, CEOs, Directors, Vice Presidents, Co-executives, Bio technologists, Managing Directors, Industry Safety Officers, Environmental and Plant Scientists, Doctorates, Professors, Post Doctorate Fellows, Vendors of Consumer Products/Managers, Pharmaceutical Scientists, Students from the related fields.

Why Attend???

Euro vaccines 2018  gives a worldwide stage to trading thoughts and makes us overhauled about the most recent advancements in the field of Vaccine, Immunization and Vaccination. The chance to go to the presentations conveyed by Eminent Scientists from everywhere throughout the world.

Target Audience:

·         Eminent personalities

·         Directors/Managers

·         Head of Departmental

·         Presidents/Vice Presidents

·         CEO's of biotech companies

·         Professors, Associate and Assistant professors

·         Doctors

·         Research Scholars and students from the related fields

·         Other experts in Vaccines


·         Acknowledged modified works will be distributed in specified journals with DOI.

·         Ecumenical systems administration: In exchanging and trading Conceptions.

·         Master Forums.

·         Best Poster Awards.

·         Best Start-Up Awards.

·         Pre-conference and Conference Workshops.

·         Symposiums on Latest Research.

      We welcome everyone to participate in “Euro Vaccines 2018” at Amsterdam, Netherlands.

Welcome Message

Allied Academies invites all the participants from all over the world to attend "International Conference on Vaccines and Immunology”, on June 28-29, 2018 in Amsterdam, Netherlands which includes prompt keynote presentations, oral talks, poster presentations, sponsors and exhibitions.

Allied Academies is a scientific association known for promoting scientific temperament and has been performing very well in Business and Management and is a perfect platform for our readers. It is established in the year 1997. The main motto is making the information on science and technology. It is a specialized medical and science publisher that operates in collaboration with the association and societies.  This publishing house has been built on the base of esteemed academic and research institutions including The College of Audiologists and Speech Language Pathologists of Ontario (CASLPO), The Association for Public Safety Communications Officials of Canada (APCO), The Canadian Vascular Access Association (CVAA), and The Canadian Society of Internal Medicine (CSIM).


Sessions/ Tracks

A vaccine is a Biological method in which a weakened or killed forms of disease causing microbe is induced to an organism to immunize him against that particular diseases.

Term vaccine and vaccination derived from variolae vaccine (smallpox of cow) invented by Edward Jenner so he is known as father of vaccines.

Vaccine is an artificial way to induce active acquired immunity to an individual organism. Vaccination is most effective way to preventing several diseases including influenza, chicken pox, polio, measles and tetanus.

Vaccines are currently available for only a limited number of viral and bacterial diseases but new systems are being developed for the more efficient production of vaccines, especially for influenza. Most of the new vaccines for autoimmune diseases, cancer and Ebola are on clinical trial stage. In near future, most safe and effective vaccines will be developed against a number of other viral and bacterial infections as well as fungal and protozoan diseases and other non-conventional diseases.             


Track 1: Vaccine & Immunization

An antibody is an organic planning that gives dynamic gained insusceptibility to a specific illness. The specialist animates the body's insusceptible framework to perceive the operator as a danger, wreck it, and keep a record of it, so that the invulnerable framework can all the more effortlessly perceive and pulverize any of these smaller scale life forms that it later experiences. An inoculation is the infusion of an executed or debilitated creature that produces insusceptibility in the body against that life form. A vaccination is the procedure by which a man or creature gets to be shielded from a malady Vaccines cause inoculation, and there are additionally a few ailments that cause vaccination after an individual recuperates from the illness. Antibodies work truly well. Obviously, no pharmaceutical is impeccable yet most adolescence antibodies deliver insusceptibility around 90-100% of the time.

Track 2: Latest developed vaccines

     In current era diseases are common which leads by several infections by different parasites like virus, bacteria, fungi, nematodes etc. To get rid of these diseases vaccination is the most effective solution. Vaccination is nothing but immunization of an individual. Immunizations are a clinical item that is made out of live or dead material from an irresistible specialist – bacterium, infection, organism or parasite – that inspire defensive invulnerability against the pathogen when controlled. These substances are utilized to keep the spread of irresistible illnesses.  

        Track 3: HIV/AIDS

Immunizations given before you get tainted are called "preventive antibodies" or "prophylactic immunizations" and you get them while you are sound. This permits your body to set up barriers against those perils early. HIV assaults and devastates the disease battling CD4 cells of the safe framework. The loss of CD4 cells makes it troublesome for the body to battle contaminations and certain diseases. Without treatment HIV can steadily pulverize the resistant framework and progress to AIDS. A restorative HIV antibody is an immunization that is intended to enhance the body's insusceptible reaction to HIV in a man who is as of now tainted with HIV. There are at present no restorative HIV immunizations affirmed by the Food and Drug Administration yet research is under way.

Track 4: Vaccines & Immunotherapy

The vaccine is a biological preparation that enhances resistance to specific infection. It contains particular operators that look like an illness bringing about the microorganism as well as animates body's safe framework to perceive the outside specialists. A vaccine is dead or inactivated life forms or refined items gotten from them. Entire creature antibodies cleaned macromolecules as vaccines, recombinant antibodies, DNA antibodies. The insusceptible framework perceives vaccine specialists as remote, devastates them, and "recollects that" them.

Immunotherapy is a standout amongst the most energizing ranges of new disclosures and medicines for various sorts of a tumor. Seeing how the insusceptible framework functions are opening the ways to grow new medicines that are changing the way we consider and treat growth. The vast majority accepting immunotherapies are dealt with in particular malignancy focuses and a large portion of them are selected in clinical trials. This may change as more trials are finished and more medications are affirmed by the Food and Drug Administration (FDA) to treat various types of malignancy.

Track 5: Immunological Clinical Practices &Trials

An Immunological Clinical trial is a unique research program designed to cultivate a collaborative environment that allows basic and translational immunologists to work side-by-side with clinicians. Clinical trial & Practices are always designed to gain some knowledge about something not yet well-known or proven. A person may volunteer to participate in a clinical study. A physician may recommend a patient to consider volunteering for specific study participation, as part of the patient therapeutic treatment options.  Clinical trials are highly regulated and are conducted following strict scientific standards in order to protect patients and to produce meaningful results. The clinical trial allows accelerating the bench-to-bedside transition of innovative immunotherapies, with much attention given to critical diseases which are known to relapse or is refractive to conventional treatments currently available. Many of the novel immunotherapy approaches, which originated from basic science research by the clinical trial and practices, are now being explored as new treatment modalities in patients, with a significant number advancing through clinical trials towards FDA approval.

Track 6: Immunological Disorders

Immune system is an organized intricate network of cells and organs that protects our body from invading foreign pathogens. This defence centre provides immunity which provides shelter from both disease and infection. Disfunctioning of such supportive center leads to Immune deficiency, which in turn induce Immunodeficiency disorders. These disorders impair the immune system’s ability to defend the invading foreign cells. They are primarily caused by genetic mutations and are inherited. Secondarily immune deficiencies are acquired from a foreign pathogen like virus or by using immune suppression drugs. There’s a situation where the immune system attacks the healthy cells within, which induce infection and disease termed as autoimmune disease. These in turn affects many parts of the body. These are more likely to occur in women of American countries.

Track 7: Production & Effectiveness of vaccines

Vaccine production has numerous ranges. First, the antigen itself is generated. Viruses are grown either on a single cell i.e. on chicken eggs or on non-stop mobile lines including human cell lines. The microorganism is grown in bioreactors Likewise, a recombinant protein derived from the viruses or microorganism can be generated in yeast. After the antigen is generated it is isolated from the cell by inactivating the virus. Recombinant proteins need many operations concerning ultrafiltration and column chromatography to be purified. Eventually, the vaccine is formulated by using adding adjuvants, stabilizers, and preservatives as needed. The adjuvant complements the immune reaction of the antigen, stabilizers increase the garage life, and preservatives allow using multidose vials as Aggregate vaccines are more difficult to broaden and bring.

Track 8: Veterinary vaccines

Vaccination of creatures are utilized both to keep their contracting sicknesses and to counteract transmission of illness to humans. Both creatures kept as pets and creatures raised as domesticated animals are routinely immunized to prevent infections transmitted from wild categories. In a few cases, wild populations might be inoculated. While it is the case of transmitted diseases and zoonotic diseases. There are several vaccines are available and research going on in development of several veterinary vaccines. I.e. rabies, canine distemper, canine parvovirus, irresistible canine hepatitis, adenovirus-2, leptospirosis, brocatelle, canine Parainfluenza infection, and Lyme ailment, and others.

Track 9: Cancer vaccines & Immunotherapy

A tumor inoculation is a counter acting agent that either treats existing development or hinders progression of a danger. Inoculations are given to guarantee against particular afflictions, for instance, cervical, prostate and bladder illnesses and defilements by boosting your invulnerable structure. Vaccinations give insusceptibility so the body creates antibodies without truly getting the illness. Development treatment antibodies, also called accommodating inoculations, are a sort of immunotherapy. The antibodies work to assist the body's basic resistances with battling a malady. The vaccinations may keep the harm from returning, annihilate any illness cells still in the body after other treatment and Stop a tumor from creating or spreading. Development antibodies cause the safe system to attack cells with no less than one specific antigen. Since the Vaccines safe system has extraordinary cells for memory, it's assumed that the inoculation may continue working long after it's given.

      Track 10: Pediatric vaccines

There are several vaccines for infants, newborn and small child’s up to 6 years and also for pregnant women’s which helps a newborn to be safe from several deadly and infectious disease so nowadays vaccination for babies are mandatory until unless the child has special circumstances, such as a compromised immune system or a neurological disorder.                                        

Track 11: Types of Vaccines

Vaccines are nothing but dead or inactivated organisms or purified products derived from them. The toxins or surface protein present on that microbe acts as a foreign antigen and impose response to our immune system. There are several types of vaccines in use these produced by using different strategies to reduce the risk of illness while retaining the ability to induce a beneficial immune response.

Track 12: Immunology Of Infectious Diseases    

Recent research in laboratories is primarily focused on infectious diseases in developing countries. Laboratory-based research may be supplemented by field-based studies of epidemiological and ecological aspects of infectious disease transmission and control. Current immune-mediated and infectious disease includes HIV/AIDS, Tuberculosis, Malaria, Pneumonia, Enteric Diseases, and Autoimmune diseases. In future, immunological studies concentrate on genetic regulation of the immune response, the reciprocity of innate immune system and intestinal microbial communities, the functioning and regulation of T-cell-derived cytokines and cytokines involved in the inflammation regulation. Recent studies shown that basic pathogenic mechanisms  lead to development of advanced diagnostic tools and  vaccines used in  prevention and control of infection and disease and the identification of new targets for antiviral and ant parasitic drugs. The battle between pathogens and the host immune defenses has raged for thousands of years. The immune system has succeeded in exploring varied approaches to control parasitic infections ranging from direct killing to developing cytokines that hamper replication.  Pathogens are encountered with developing immune evasion mechanisms that inhibit functioning of cytokines and arrest immune recognition of infected cells. Efforts carried out to interpret and signalize the opposing mechanisms will assuredly generate improvised treatment of infectious diseases ranging from AIDS and parasitic infections to sexually transmitted diseases and the common cold.

Track 13: Immunoresearch & Immunotechnology

Immunology is worried about the utilization of immunological responses for the determination, avoidance, and treatment of various infections. It is firmly identified with therapeutic and veterinary microbiology, the study of disease transmission, physiology and Pathophysiology, organic chemistry, and endocrinology. Viral Immunology and the immunology of parasitic infections are autonomous branches of commonsense immunology. Immunology concentrates the antigenic creation of microorganisms, attributes of the safety procedures in different sorts of contaminations, and nonspecific types of Imperviousness to the causative operators of irresistible infections. Investigation of the immunological procedures and the immunological reproduction of the living being created by Non-infectious Antigens of the exogenous and endogenous starting point and the advancement of strategies for controlling unfavorably susceptible sicknesses are winding up noticeably progressively imperative. Different branches of clinical immunology are likewise growing seriously. These incorporate radiation immunology, which concentrates the disturbance of immunological reactivity by illumination, and Immunohematology, which researches the antigenic piece of platelets and the causes and instrument of advancement of immunological harm to the circulatory framework. Immunology is creating techniques for Immunoprophylaxis, Immunotherapy, and Immunodiagnostics. Immunologic Research speaks to an interesting medium for the introduction, translation, and elucidation of complex logical information. 

Track 14: Human Vaccines-infectious & non- infectious

An immune response is an inactivated kind of microorganisms or contamination that is imbued into the body to reenact a bona fide ailment. Since the implanted microorganisms are "dead" they don't achieve a man to twist up wiped out. Or maybe, antibodies vivify a protected response by the body that will fight off that sort of disorder. It covers overpowering ailment targets and non-overwhelming disease targets. To deliver immune response mediated security is a puzzling test. At present open antibodies have, all things considered, been made observationally, with for all intents and purposes zero appreciation on how they incite the immune system. Their underlying guarded practicality is essentially exhibited by the acknowledgment of antigen-specific antibodies. In any case, there is an entire other world to neutralizing operator interceded security than the zenith of vaccination activated immunizer titers.

Track 15: Vaccine adjuvants & delivery technologies

An adjuvant is a substance that is added to a counter acting agent to assemble the body's safe response to the vaccination. An adjuvant is a component of a vaccination that makes a more grounded safe response in the patient's body. By the day's end adjuvants help antibodies work better. A couple of inoculations created utilizing crippled or dead germs contain ordinarily happening adjuvants and help the body convey a strong protective insusceptible response. In any case, most antibodies developed today fuse basically little portions of germs, for instance, their proteins, instead of the entire disease or microorganisms. There is starting now genuine research development went for the headway of new movement systems for antibodies. The vaccines goal is to perceive perfect skill for showing target antigens to the resistant structure in a way that will inspire immune responses reasonable for protection against, or treatment of a specific sickness.

Track 16: Vaccines for unconventional diseases

Vaccination against infectious diseases are very common but now a days antibody-inducing vaccines are introduced which can direct against non-infectious diseases and some unconventional indications. These vaccines are introduced far before. But still, in promising late stage with some exceptional failures, there is still no counteracting agent prompting immunization other than microorganism antigens I.e focusing on self-antigens, enslavement atoms antigens and others. Several clinical trials might have given us a golden fruit soon on this research.

Track 17: Plant –based vaccines

Plant-based vaccines are recombinant protein subunit vaccines. Ideally, the choice of plant species used to produce the selected antigen should allow for oral delivery in the form of an edible vaccine. These vaccines are well suited to combat diseases where there is a clear antigen candidate, and where the costs of production or delivery for any current vaccine are prohibitive. Several academic and industrial research groups are currently investigating the use of plant-based vaccines in both humans and animals. To date, the most advanced human vaccine projects have successfully completed phase I clinical trials, and animal vaccine projects have given promising data in early phase trials targeting specific animal species.

Track 18: Vaccines safety & efficiency

For the past two decades, vaccines have used for preventing a number of  infectious diseases in a safe and effective way. Although the safety of some vaccines has been under threat in recent years, the currently available vaccines are more than a million times safer than the diseases they are meant for. Proper concern and education about vaccines are necessary so that peoples should be aware of it and know about its use and effectiveness because the general public believed that vaccines are unsafe and not needed. Now vaccines are not only given via injection but also given orally or intranasal so peoples will get proper benefit from it.

Track 19: Current research & future challenges in vaccines

Vaccine production is challenging as vaccine Development not only depends on sophisticated mechanism but also on the novel antigen, adjuvant, and Expression vector along with proper information and clinical study about virulence, pathogenesis, and genetics of pathogen and microbe. Vaccines are currently available for only a limited number of viral and bacterial diseases but new systems are being developed for the more efficient production of vaccines, especially for influenza. Most of the new vaccines for autoimmune diseases, cancer and Ebola are on clinical trial stage. In near future, most safe and effective vaccines will be developed against a number of other viral and bacterial infections as well as fungal and protozoan diseases and other nonconventional diseases.

Track 20: Society & cultural aspects of vaccines

As vaccine production involved clinical trials and some animal modeling a wide range of critics are emerging by society on the value of ethics as it meant as animal sacrifice. Misguidances by several criticism peoples are unaware of the actual effectiveness of vaccines. Proper concern and education should be required to get rid of this problem. Meanwhile, vaccine production and demanding need for several high-cost vaccines like HIV, malaria, and tuberculosis affects economy of country as it funded by government and some nonprofit organizations.

Market Analysis



Amsterdam is thecapital and most crowded district of the Kingdom of Netherlands. Its status asthe capital is ordered by the Constitution of Netherlands, despite the factthat it isn't the seat of the administration, which is The Hague. Amsterdam hasa populace of 851,373 inside the city legitimate, 1,351,587 in the urbanterritory, and 2,410,960 in the Amsterdam metropolitan range. The city issituated in the area of North Holland in the west of the nation. Themetropolitan zone involves a significant part of the northern piece of theRamstad, one of the bigger conurbations in Europe, with a populace of roughly 7million. 

As the business capital of the Netherlands andone of the best monetary focuses in Europe, Amsterdam is viewed as an alphaworld city by the Globalization and World Cities ponder gather in 2012,Amsterdam was positioned the second best city tolive in by the Economist Intelligence Unit (EIU) and twelfth all-inclusive onnature of living for condition and framework by Mercer.

Market Analysis


Thismarket investigation incorporates a point by point division of theworldwide humanantibody advertise by sort of human immunization (preventablehuman immunizations and restorative human immunizations), by creation (monoantibody and blend antibodies), by course of organization (oral, intramuscular,intranasal, and intradermal), and by geology (Americas, APAC, and Europe). Thekey merchants dissected in this report are GlaxoSmithKline, Merck, Pfizer, andSanofi. 

Technavio'sstatistical surveying examiner predicts the worldwide human immunization marketto develop quickly at a CAGR of over 11% by 2020. This current market'senduring development rate is vigorously affected by the incorporation of a few pediatricantibodies in the national vaccination calendar of different nations.This aides in expanding the utilization of immunizations, which thuslyencourages showcase development amid the anticipated period. 


Developingopen mindfulness and support from both government and non-government officeswill drive the prospects for development in this market amid the gauge timeframe. As of late, it has been watched that associations like the WHO and theAssociation of American Physicians (AAP) are consistently sorting out projectsand camps to spread mindfulness about the advantages of immunization.This expansion in mindfulness will enlarge the inoculation scope over theworld, which thus will bring about market development.



Why to Attend?

·        To Meet World’s High-LevelScientific verbalizers for industry perspective.
 Learn from leading non-profit organizations and regime bodies.

·        Meet the people in your field - canlead to incipient opportunities for collaborative efforts, Incipient Tips.

·        Present your latest research infront of the world.

·        To know the current state ofresearch and the challenges to future revelation Networking.

·        Face to Face Interactions with yourfield experts.

·        Business-Business Meetings.

·        Scientific Sessions, Keynote Forum,Exhibition, Workshops, Symposia, Poster Presentations,

·        Video Presentations and StudentGuidance.

 Meet with international colleagues,make incipient friends.


Importance and scope

A vaccineis a Biological method in which a weakened or killed form of disease-causingmicrobe is induced to an organism to immunize himagainst those particular diseases. Term vaccine and vaccination derived from avariolae vaccine (smallpox cow) invented by Edward Jenner so he is known as thefather of vaccines.
A vaccine is an artificial way to induce active acquired immunity toan individual organism. Vaccinationis most effective way of preventing several diseases including influenza, chicken pox,polio, measles and tetanus.
Vaccines are currently available for only a limited number of viral andbacterial diseases but new systems are being developed for the more efficientproduction of vaccines, especially for influenza. Most of the new vaccinesfor autoimmune diseases, cancer and Ebola are on clinical trial stage. Innear future, most safe and effective vaccines will be developed against anumber of other viral and bacterial infections as well as fungal andprotozoan diseases and other nonconventional diseases.

Major Societies and AssociationsOffering Vaccines:

  • European Vaccine Manufacturers
  • The European Federation of Pharmaceutical Industries and Associations
  • Sclavo Vaccines Association
  • The European Malaria Vaccine Development Association
  • WHO
  • The International Society for Interferon and Cytokine Research
  • The International Union of Immunological Societies
  • The Society for Mucosal Immunology
  • Federation of Clinical Immunology Societies
  • Immune Deficiency Foundation
  • Infectious Diseases Society of America
  • The Society for Leukocyte Biology
  • Transplantation Society
  • British Society for Immunology
  • The International Society of Neuroimmunology
  • European Society of Gene Therapy
  • Federation of African Immunological Societies
  • Federation of American Societies for Experimental Biology

CompaniesOffering Vaccines in World:

  • Antisense Therapeutics Limited
  • GlaxoSmithKline Australia Pty Ltd
  • Bionomics
  • Australian Pharmaceutical Industries (GSK)
  • Sanofi
  • Merck
  • Pfizer
  • Novartis(GSK)
  • CSL
  • Medimmune
  • J&J(Crucell)
  • China National Biotec
  • Tiantan
  • Hualan
  • Kangtai
  • Jintan

Major Universities associated withVaccine and Vaccination research

·        University of Cambridge

·        London School of Hygiene andTropical Medicine

·        Imperial College London

·        UCL Institute of Epidemiology andHealthcare

·        University of Sheffield

·        Pediatric Infectious DiseasesSociety

·        Columbia University

·        University of Maryland

·        Swedish Institute of InfectiousDisease Control

·        Uppsala University

·        University of Gothenburg

·        Oslo University

·        University of Glasgow

·        University of Pittsburgh

·        Emory Health Sciences

·        University of Liverpool

·        University of Colorado Denver  

·        Medical College of Georgia atGeorgia Regents University 

·        Kings College of London

·        Queensland University of Technology

·        University of Otego

·        Georgia State University, Atlanta

·        University of Aberdeen

Organizing Committee Member
OCM Member
Pierre A. MORGON
MRGN Advisors
Switzerland, Switzerland
OCM Member
Giulio Filippo Tarro
President, Department of Biology, Virology and Cancer Research
Foundation T. and L. de Beaumont Bonelli for Cancer Research
Naples, Italy
OCM Member
Ivana Haluskova Balter
Administrative Board Member
French society of immunology
Paris, France
OCM Member
Zelalem Bitsue
Owner, Founder and G.Director
United States of Africa Health Organization
Pretoria, South Africa
OCM Member
Andreas Weinhäusel
Molecular Diagnostics, Center for Health & Bioresources, Molecular biology
Austrian Institute of Technology
Vienna, Austria
OCM Member
Tilahun Yilma
University of California, Davis, CA 95616, USA
Los Angeles, USA
OCM Member
Zlatko Dembic
Professor, Immunology, cell-biology and microbiology
University of Oslo, Oslo, Norway
Trondheim, Norway
OCM Member
Mariam Makame
Executive Director
Usaidizi Orphans Organization
Dar es Salaam, Tanzania
OCM Member
Henry M. Sobell
University of Rochester, USA
Los Angeles, USA
OCM Member
Nerin Nadir Bahceciler Onder
Professor, Allergy and Immunology
Near East University, faculty of medicine, department of pediatrics, Division of Allergy & Immunology
Cyprus, Cyprus
OCM Member
Selcuk University
Selcuk University
Istanbul, Turkey
OCM Member
Mohammad Hossein Yazdi
Assistant Professor
Tehran University of Medical Sciences, Tehran, Iran
Tehran, Iran
OCM Member
Aasim wani
Research Associate
Division of Veterinary Microbiology, SKUAST-K, India
Rishikesh, India

Hyatt Place Amsterdam Airport 
Rijnlanderweg 800, 2132 NN Hoofddorp, Netherlands

T +31 20 542 1280, M +31 6 579 95252


Join The Discussion

Allied Academies Global Conference Directory

Mail us at

Drop us an email for Program enquiry
General Queries
More details about

Terms and Conditions


The organizers holds no responsibilities or liabilities of the personal articles of attendees at the venue against any kind of theft, lost, damage, due to any reason whatsoever. Delegates are entirely responsible for the safety of their own belongings.



No insurance, of any kind, is included along with the registration in any of the events of the organization.


Please note that transportation and parking is the responsibility of the registrant, Allied Academies will not be liable for any actions howsoever related to transportation and parking.



Press permission must be obtained from Allied Academies Conference Organizing Committee prior to the event. The press will not quote speakers or delegates unless they have obtained their approval in writing. The Allied Academies is an objective third-party nonprofit organization and this conference is not associated with any commercial meeting company.

Requesting an Invitation Letter

For security purposes, letter of invitation will be sent only to those individuals who had registered for the conference after payment of complete registration fee. Once registration is complete, please contact to request for a personalized letter of invitation, if not received until one month before the scheduled date of event.

All the bank charges applicable during refund will be deducted from the account of participant.

Cancellation Policy

All cancellations or modifications of registration must be made in writing to

If, due to any reason, Allied academies postpone an event on the scheduled date, the participant is eligible for a credit of 100% of the registration fee paid. This credit shall only be used for another event organized by Allied academies within period of one year from the date of rescheduling. 

Postponement of event

If, due to any reason, Allied academies postpone an event and the participant is unable or unwilling to attend the conference on rescheduled dates, he/she is eligible for a credit of 100% of the registration fee paid. This credit shall only be used for another event organized by Allied academies within period of one year from the date of rescheduling.

Transfer of registration

All registrations, after payment of complete registration fee, are transferable to other persons from the same organization, if in case the person is unable to attend the event. Request for transfer of registration must be made by the registered person in writing to Details must include the full name of replaced new registrant, their title, contact phone number and email address. All other registration details will be assigned to the new person unless otherwise specified.

Registration can be transferred to one conference to another conference of Allied academies if the person is unable to attend one of conferences.

However, Registration cannot be transferred if intimated within 14 days of respective conference.

The transferred registrations will not be eligible for Refund.

This cancellation policy was last updated on April 04, 2015.

Visa Information

Keeping in view of increased security measures, we would like to request all the participants to apply for Visa as soon as possible.

Allied academies will not directly contact embassies and consulates on behalf of visa applicants. All delegates or invitees should apply for Business Visa only.

Important note for failed visa applications: Visa issues are not covered under the cancellation policy of Allied academies, including the inability to obtain a visa.

Refund Policy:

If the registrant is unable to attend, and is not in a position to transfer his/her participation to another person or event, then the following refund policies apply:

Keeping in view of advance payments towards Venue, Printing, Shipping, Hotels and other overhead charges, following Refund Policy Orders are available:

  • Before 60 days of the conference: Eligible for Full Refund after deduction of $100 towards service Fee.
  • Within 60-30 days of Conference: Eligible for 50% of payment Refund
  • Within 30 days of Conference: Not eligible for Refund
  • E-Poster Payments will not be refunded.

Accommodation Cancellation Policy:

Accommodation Service Providers (Hotels) have their own cancellation policies which are applicable when cancellations are made less than 30 days prior to arrival. If in case the registrant wishes to cancel or amend the accommodation, he/ she is expected to inform the organizing authorities on a prior basis. Allied academies will advise the registrant to ensure complete awareness about the cancellation policy of your accommodation provider, prior to cancellation or modification of their booking.


Copyright © 2019-2020 Allied Academies, All Rights Reserved.